-
1
-
-
0030944361
-
Seronegative myasthenia gravis
-
SANDERS, D. B., I. ANDREWS, J. F. HOWARD et al. 1997. Seronegative myasthenia gravis. Neurology 48(suppl. 5): S40-S45.
-
(1997)
Neurology
, vol.48
, Issue.5 SUPPL.
-
-
Sanders, D.B.1
Andrews, I.2
Howard, J.F.3
-
2
-
-
0027301234
-
Seronegative myasthenia gravis: Evidence for plasma factor(s) interfering with acetylcholine receptor function
-
VINCENT, A., Z. LI, A. HART et al. 1993. Seronegative myasthenia gravis: evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann. N.Y. Acad. Sci. 681: 529-538.
-
(1993)
Ann. N.Y. Acad. Sci.
, vol.681
, pp. 529-538
-
-
Vincent, A.1
Li, Z.2
Hart, A.3
-
3
-
-
0021984644
-
Diaphragmatic myasthenia in mother and child
-
MIER, A. K. & J. N. HAVARD. 1985. Diaphragmatic myasthenia in mother and child. Postgrad. Med. J. 61: 725-727.
-
(1985)
Postgrad. Med. J.
, vol.61
, pp. 725-727
-
-
Mier, A.K.1
Havard, J.N.2
-
4
-
-
0022648551
-
Myasthenia gravis without acetylcholine-receptor antibody: A distinct disease entity
-
MOSSMAN, S., A. VINCENT & J. NEWSOM-DAVIS. 1986. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet i: 116-119.
-
(1986)
Lancet
, vol.1
, pp. 116-119
-
-
Mossman, S.1
Vincent, A.2
Newsom-Davis, J.3
-
5
-
-
0025312039
-
A myasthenia gravis plasma im munoglobulin reduces miniature endplate potentials at human endplates in vitro
-
BURGES, J., D. W. WRAY, S. PIZZIGHELLA et al. 1990. A myasthenia gravis plasma im munoglobulin reduces miniature endplate potentials at human endplates in vitro. Muscle Nerve 13: 407-413.
-
(1990)
Muscle Nerve
, vol.13
, pp. 407-413
-
-
Burges, J.1
Wray, D.W.2
Pizzighella, S.3
-
6
-
-
0026002993
-
Seronegative myasthenia gravis: A plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM
-
YAMAMOTO, T., A. VINCENT, T. A. CIULLA et al. 1991. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann. Neurol. 30: 550-557.
-
(1991)
Ann. Neurol.
, vol.30
, pp. 550-557
-
-
Yamamoto, T.1
Vincent, A.2
Ciulla, T.A.3
-
7
-
-
0028051373
-
Seronegative myasthenia gravis plasmas reduce acetylcholine-induced currents in TE671 cells
-
BARRETT-JOLLEY, R., N. BYRNE, A. VINCENT et al. 1994. Seronegative myasthenia gravis plasmas reduce acetylcholine-induced currents in TE671 cells. Pflügers Arch. 428: 492-498.
-
(1994)
Pflügers Arch.
, vol.428
, pp. 492-498
-
-
Barrett-Jolley, R.1
Byrne, N.2
Vincent, A.3
-
8
-
-
0024575657
-
Protein phosphorylation of nicotinic acetylcholine receptors
-
HUGANIR, R. L. & K. MILES. 1989. Protein phosphorylation of nicotinic acetylcholine receptors. Crit. Rev. Biochem. 24: 183-215.
-
(1989)
Crit. Rev. Biochem.
, vol.24
, pp. 183-215
-
-
Huganir, R.L.1
Miles, K.2
-
9
-
-
0029959047
-
Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: A role in seronegative myasthenia gravis?
-
LI, Z., N. FORESTER & A. VINCENT. 1996. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: a role in seronegative myasthenia gravis? J. Neuroimmunol. 64: 179-184.
-
(1996)
J. Neuroimmunol.
, vol.64
, pp. 179-184
-
-
Li, Z.1
Forester, N.2
Vincent, A.3
-
10
-
-
0029874077
-
Stable high level expression of the adult subtype of human muscle acetylcholine receptor in the TE671 cell line following transfection with cDNA encoding the e subunit
-
BEESON, D., M. AMAR, I. BERMUDEZ et al. 1996. Stable high level expression of the adult subtype of human muscle acetylcholine receptor in the TE671 cell line following transfection with cDNA encoding the e subunit. Neurosci. Lett. 207: 57-60.
-
(1996)
Neurosci. Lett.
, vol.207
, pp. 57-60
-
-
Beeson, D.1
Amar, M.2
Bermudez, I.3
-
11
-
-
0024559229
-
Detection of NGF and EGF-regulated protein kinases in PC12 cells with synthetic peptide substrates
-
HEASLEY, L. E. & G. L. JOHNSON. 1989. Detection of NGF and EGF-regulated protein kinases in PC12 cells with synthetic peptide substrates. Mol. Pharmacol. 35: 331-338.
-
(1989)
Mol. Pharmacol.
, vol.35
, pp. 331-338
-
-
Heasley, L.E.1
Johnson, G.L.2
|